ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 | Synapse
February 28, 2026
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
Key Points
Key points are not available for this paper at this time.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
A Wed, study studied this question.
synapsesocial.com/papers/6a025a619cddff7633412bbb
https://doi.org/https://doi.org/10.1056/nejmc2518635
Mark Helpful
Like
Save
Bookmark
Relay
Share